3,121
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Economic evaluation of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer: systematic review and quality assessment

, , , &
Pages 1001-1010 | Received 14 Jul 2020, Accepted 02 Sep 2020, Published online: 24 Sep 2020

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.